Yorktown Management & Research Company’s AbbVie ABBV Stock Holding History

Yorktown Management & Research Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,350	Closed	-$466K	–	248
2020 Q4	$466K	Buy	4,350 +580	+15%	+$55.7K	0.42%	91
2020 Q3	$330K	Buy	3,770 +220	+6%	+$20.7K	0.31%	170
2020 Q2	$349K	Sell	3,550 -7,750	-69%	-$682K	0.31%	102
2020 Q1	$861K	Sell	11,300 -7,150	-39%	-$609K	0.87%	7
2019 Q4	$1.63M	Buy	18,450 +1,450	+9%	+$120K	0.88%	7
2019 Q3	$1.29M	Hold	17,000	–	–	0.69%	12
2019 Q2	$1.24M	Hold	17,000	–	–	0.47%	45
2019 Q1	$1.37M	Hold	17,000	–	–	0.44%	49
2018 Q4	$1.57M	Sell	17,000 -2,800	-14%	-$246K	0.52%	48
2018 Q3	$1.87M	Buy	19,800 +2,000	+11%	+$190K	0.55%	46
2018 Q2	$1.65M	Hold	17,800	–	–	0.48%	47
2018 Q1	$1.69M	Sell	17,800 -1,400	-7%	-$154K	0.5%	45
2017 Q4	$1.86M	Buy	19,200 +15,000	+357%	+$1.41M	0.54%	40
2017 Q3	$373K	Buy	+4,200	New	+$320K	0.1%	143
2016 Q1	–	Sell	-56,900	Closed	-$3.37M	–	361
2015 Q4	$3.37M	Buy	56,900 +1,900	+3%	+$109K	0.6%	44
2015 Q3	$2.99M	Buy	55,000 +15,000	+38%	+$976K	0.5%	57
2015 Q2	$2.69M	Buy	40,000 +20,000	+100%	+$1.31M	0.47%	63
2015 Q1	$1.17M	Buy	+20,000	New	+$1.21M	0.21%	104

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Yorktown Management & Research Company's ABBV Position: Q1 2021 in Review

Yorktown Management & Research Company sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 4,350 shares — an estimated $466K sold.

Yorktown Management & Research Company first reported a position in ABBV in Q1 2015 and held it in 18 quarters. The position peaked at $3.37M in Q4 2015. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

Yorktown Management & Research Company reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
Yorktown Management & Research Company sold 4,350 AbbVie shares in Q1 2021, an estimated $466K.
Yorktown Management & Research Company first reported a position in AbbVie in Q1 2015 and held it in 18 quarters.
Yorktown Management & Research Company's AbbVie position peaked at $3.37M in Q4 2015.
2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Yorktown Management & Research Company's 13F filing for Q1 2021, filed 11 May 2021.